Yubo International Biotech Limited
YBGJ----
Yubo International Biotech Limited (YBGJ)
Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offer...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
News
- TradingView ·
Yubo International Biotech Ltd 2Q 2026: Revenue $165.49K, Net income ($268.72K), EPS $0— 10-Q Summary
- PUBT ·
Yubo International Biotech Q2 FY26 net loss widens 7.6% to $268,721; revenue holds at no revenue
- Earnings Watch ·
Yubo International Biotech Limited | 10-K: FY2025 Revenue: USD 12.35 K
- Wallstreetcn ·
Yubico's stock price drop widened to 30%
- TradingView ·
Chungui International BioTech, Biofermented Health Wines, Files for Nasdaq Capital Market IPO
- Tip Ranks ·
Bure Equity Hit by Sharp NAV Decline as Tech Portfolio Repriced in 2025
